NanoAssemblr® Blaze™

NanoAssemblr® Blaze™
Product Description

The NanoAssemblr® Blaze™ allows rapid scaling of nanoparticle formulations for late pre-clinical development. The system can manufacture between 10 mL and 10 L of formulation which allows researchers to use the Blaze for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) studies.

Precision NanoSystems

  • Country/Region:
    Canada
  • On CPHI since:
    2018
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Manufacturer/Innovator
Primary activities
Biopharmaceutical

Precision NanoSystems

  • Country/Region:
    Canada
  • On CPHI since:
    2018
  • Employees:
    100 - 249
Company types
Biopharmaceutical company
Manufacturer/Innovator
Primary activities
Biopharmaceutical

More Products from Precision NanoSystems (2)

  • NanoAssemblr® Spark™

    Product NanoAssemblr® Spark™

    Transformative medicines start with novel materials that can be costly or in limited supply. The NanoAssemblr® Spark™ is ideal for screening novel genetic medicine formulations because it provides unmatched sample recovery, intuitive operation, rapid production, robust process to minimize user variabi...
  • NanoAssemblr® Ignite™

    Product NanoAssemblr® Ignite™

    Genomic medicines have a wide design space that requires optimization to select a lead candidate. The NanoAssemblr® Ignite™ is ideal for fine tuning process parameters and compositions for further scale up to the clinic.

    Easily scale between 1mL and 20mL formulations on the Ignite™. Optimiz...